And another one | Pfizer develops booster shots to take after COVID vaccines;
Read Time:35 Second
The pharmaceutical giant announced Thursday it plans to ask the FDA for authorization to offer a third dose six to 12 months after the second to help take on the delta variant.
- Clinical studies could begin as early as August, subject to regulatory approvals.
- Executives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.
- The companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the “highest levels” of protection against all currently known variants, including delta, they are “remaining vigilant” and developing an updated version of the vaccine.
SOURCE: CNBC
Happy
0
0 %
Sad
0
0 %
Excited
0
0 %
Sleepy
0
0 %
Angry
0
0 %
Surprise
0
0 %
